Intravenous news: attorneyatlaw.com report “Relatives of a Texas man who died after receiving a contaminated dose of the blood thinner heparin have filed a lawsuit against the drugs maker, the medical facility where the dose was administered, and others.
Lloyd James Robinson was given the anticoagulant heparin at the Lufkin Dialysis center, according to the lawsuit filed on Dec. 30. After the drug was administered, Robinson suffered a hypersensitivity-type adverse reaction and died, according to the lawsuit and a report in the Southeast Texas Record.
Heparin is widely used to prevent blood clots from forming during surgical procedures and to keep intravenous lines clear of blockages. In 2008, Baxter International Inc., a leading maker of heparin, announced a recall of all lots of the drug after it was determined that some doses were tainted with a counterfeit active ingredient provided by a Chinese manufacturer.
About 100 patient deaths and adverse reactions have been linked to the contaminated doses of heparin.
Robinsons product-liability lawsuit accuses Baxter of using a Chinese manufacturer that did not adhere to United States regulations and of negligence for failing to act reasonably as a prudent drug manufacturer.”
Click here for the full story.